Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia

General Hospital Psychiatry

Volumn 31, Issue 2, 2009, Pages 146-154

  Fortuyn, Hal A Droogleever ^a   Lappenschaar, G A ^a   Nienhuis, Fokko J ^b   Furer, Joop W ^a   Hodiamont, Paul P ^a,c   Rijnders, Cees A ^a,d   Lammers, Gert Jan ^e   Renier, Willy O ^a   Buitelaar, Jan K ^a   Overeem, Sebastiaan ^a,f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d Institute for Mental Health Care Breburg Group   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Delusions; Hallucinations; Narcolepsy; Psychiatric; Schizophrenia

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; AUDITORY HALLUCINATION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELUSION; DESCRIPTIVE RESEARCH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; HYPNAGOGIC HALLUCINATION; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PHENOMENOLOGY; POPULATION; PREVALENCE; PSYCHOSIS; QUALITATIVE RESEARCH; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SYMPTOM;

ADULT; CROSS-SECTIONAL STUDIES; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; NARCOLEPSY; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 61349158753     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.12.002     Document Type: Article

References (39)

1. Overeem S., Scammell T.E., and Lammers G.J. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol 15 6 (2002) 739-745
2. Harris G.C., Wimmer M., and Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 7058 (2005) 556-559
3. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., and Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148 6 (2006) 752-759
4. Deutch A.Y., and Bubser M. The orexins/hypocretins and schizophrenia. Schizophr Bull 33 6 (2007) 1277-1283
5. Kondziella D., and Arlien-Soborg P. Diagnostic and therapeutic challenges in narcolepsy-related psychosis. J Clin Psychiatry 67 11 (2006) 1817-1819
6. Szucs A., et al. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand 108 4 (2003) 314-316
7. Schrader G., et al. Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia. J Nerv Ment Dis 172 7 (1984) 439-441
8. Pfefferbaum A., and Berger P.A. Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma. J Nerv Ment Dis 164 4 (1977) 293-297
9. Kishi Y., Konishi S., Koizumi S., Kudo Y., Kurosawa H., and Kathol R.G. Schizophrenia and narcolepsy: a review with a case report. Psychiatry Clin Neurosci 58 2 (2004) 117-124
10. Douglass A.B., Shipley J.E., Haines R.F., Scholten R.C., Dudley E., and Tapp A. Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biol Psychiatry 34 11 (1993) 773-780
11. Ohayon M.M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 97 2-3 (2000) 153-164
12. Brugha T.S., Jenkins R., Taub N., Meltzer H., and Bebbington P.E. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 31 6 (2001) 1001-1013
13. ICSD. International classification of sleep disorders. 2nd ed. (2005), American Academy of Sleep Medicine, Westchester (IL)
14. Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering R., and Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry 68 5 (2007) 654-661
15. Wunderink L., Nienhuis F.J., Sytema S., and Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull 33 3 (2007) 792-796
16. Hodiamont P.P., et al. Psychiatric disorders in a Dutch Health Area: a repeated cross-sectional survey. J Aff Dis 84 1 (2005) 77-83
17. Rijnders C.A., van den Berg J.F., Hodiamont P.P., et al. Psychometric properties of the schedules for clinical assessment in neuropsychiatry (SCAN-2.1). Soc Psychiatry Psychiatr Epidemiol 35 8 (2000) 348-352
18. Wing J.K., Babor T., Brugha T., et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47 6 (1990) 589-593
19. Kampman O., Kiviniemi P., Koivisto E., et al. Patient characteristics and diagnostic discrepancy in first-episode psychosis. Compr Psychiatry 45 3 (2004) 213-218
20. Vourdas A., Shneerson J.M., Gregory C.A., et al. Narcolepsy and psychopathology: is there an association?. Sleep Med 3 4 (2002) 353-360
21. Nylund K.L., Asparouhov T., and Muthen B. Deciding on the number of classes in latent class analysis and growth mixture modeling; a Monte Carlo simulation study. Struct Equat Mod 14 (2007) 535-569
22. Dahmen N., Kasten M., Mittag K., and Muller M.J. Narcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiology. Eur J Health Econ 3 Suppl 2 (2002) S94-S98
23. Douglass A.B., Hays P., Pazderka F., and Russell J.M. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 179 1 (1991) 12-17
24. Walterfang M., Upjohn E., and Velakoulis D. Is schizophrenia associated with narcolepsy?. Cogn Behav Neurol 18 2 (2005) 113-118
25. Auger R.R., Goodman S.H., Silber M.H., Krahn L.E., Pankratz V.S., and Slocumb N.L. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep 28 6 (2005) 667-672
26. Webster R., and Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics 41 6 (2000) 519-522
27. Breitbart W., Gibson C., and Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43 3 (2002) 183-194
28. Cubells J.F., Feinn R., Pearson D., et al. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP). Drug Alcohol Depend 80 1 (2005) 23-33
29. McKetin R., McLaren J., Lubman D.I., and Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 101 10 (2006) 1473-1478
30. Fenelon G., Thobois S., Bonnet A.M., Broussolle E., and Tison F. Tactile hallucinations in Parkinson's disease. J Neurol 249 12 (2002) 1699-1703
31. Kiziltan G., Ozekmekci S., Ertan S., Ertan T., and Erginoz E. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol 254 4 (2007) 448-452
32. de Maindreville A.D., Fénelon G., and Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Dis 20 2 (2005) 212-217
33. Fenelon G., Goetz C.G., and Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology 66 1 (2006) 93-98
34. Sowa M.V., and Pituck S. Prolonged spontaneous complex visual hallucinations and illusions as ictal phenomena. Epilepsia 30 5 (1989) 524-526
35. Manford M., and Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 121 Pt 10 (1998) 1819-1840
36. Baska R.E. Hypothalamic-midbrain dysregulation syndrome. J Child Neurol 7 1 (1992) 116-117
37. Lhermitte J. Syndrome de la calotte du Pedoncule cerebral. Les troubles psycho-sensoriels dans les lesions du mésocéphale. Rev Neurol (Paris) 2 (1922) 1359-1365
38. D'Cruz O.F., Vaughn B.V., Gold S.H., and Greenwood R.S. Symptomatic cataplexy in pontomedullary lesions. Neurology 44 11 (1994) 2189-2191
39. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 50 2 Suppl 1 (1998) S31-S36